News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Roche (RHHBY) To Pay Up To $489 Million For Next-Gen Antibody Firm Dutalys     12/19/2014
Eli Lilly (LLY), Adocia Ink $570 Million Pact To Develop Fast-Acting Insulin     12/19/2014
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/19/2014
Vernalis PLC (VNLPY.PK) Stumbles As Novartis AG (NVS) Abandons Work On AUY922     12/19/2014
Hedged Fun Takes Stake In Salix Pharmaceuticals, Ltd. (SLXP); Other Top Investors Push For Sale Of Company     12/19/2014
Second Phase Of GlaxoSmithKline (GSK)'s Ebola Vaccine Delayed     12/19/2014
GlaxoSmithKline (GSK) Reassure Investors That Dividend Is Safe As Analysts Question Payout     12/19/2014
Alcon Laboratories, Inc. (ACL) Release: FDA Approves Xtoro To Treat Swimmer's Ear     12/19/2014
Growth Hormone Biotech Ascendis Pharma A/S Files For A $86 Million IPO     12/19/2014
Merck & Co. (MRK) Snaps Up Swiss Biotech In $375 Buyout Deal     12/18/2014
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor     12/18/2014
GlaxoSmithKline (GSK) Staffers Nervous As Job Cuts Loom     12/18/2014
Takeda (TKPYY) Snatches Sanofi (SAN.PA) Exec To Lead Global R&D     12/18/2014
Amgen (AMGN)'s Blincyto To Carry A Hefty $178,000 Price Tag     12/18/2014
SoCal's Xencor Snags $175 Million+ R&D Pact With Novo Nordisk A/S (NVO)     12/18/2014

Featured Stories
Could Ibuprofen Be An Anti-Aging Medicine? Buck Institute for Age Research Study     12/19/2014
Not Again! First Ever Case Of Anxiety-Induced déjà vu, Sheffield Hallam University Study     12/19/2014
Mount Sinai Hospital Study Identifies 53 Approved Drugs That May Block Ebola Infection     12/19/2014
Low-Dose Lithium Prevents Parkinson's Symptoms In Aged Mice With A Human Mutation For The Disease, Buck Institute for Age Research Study     12/19/2014
Tooth Loss Linked To Slowing Mind And Body, University College London Study     12/19/2014
Wild Blueberries (Bilberries) Can Help Tackle The Adverse Effects Of A High-Fat Diet, University Of Eastern Finland Study     12/19/2014
Drug Developed At University of Pittsburgh Proves Effective Against Antibiotic-Resistant "Superbugs"     12/19/2014
Skin Cancer: Painkillers Linked To Reduced Risk, University of London Study     12/19/2014
Lancet: Most Commonly Prescribed Glaucoma Drug Reduces Risk Of Vision Loss By More Than 50% Over 2 Years     12/19/2014
Will Pfizer (PFE) Still Go For A Big Acquisition?     12/18/2014
Scientific Case For Starting The Workday At 10 AM, University of Pennsylvania Study     12/18/2014
Rules For Babies "From Three People"     12/18/2014
Japan Lab Cannot Repeat Ground-Breaking Cell Finding: Reports     12/18/2014
Only 4 In 10 Americans Eat Heart-Healthy Nuts Each Day, CDC Says     12/18/2014
Pollution Doubles Autism Risk, Harvard School of Public Health Study     12/18/2014

More News
Eli Lilly (LLY)'s CYRAMZA (ramucirumab) Receives Third FDA Approval     12/18/2014
Portage's Biohaven Receives Response From FDA To Its Pre-IND Meeting Request     12/18/2014
Pivotal Phase 3 Study Of GlaxoSmithKline (GSK) Shingles Candidate Vaccine Meets Its Primary Endpoint     12/18/2014
Pfizer (PFE) Reports Top-Line Results From A Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation As A Treatment For Patients With Postherpetic Neuralgia     12/18/2014
TetraPhase Pharmaceuticals (TTPH) Announces Positive Top-Line Results From Phase 3 IGNITE 1 Clinical Trial Of Eravacycline In Complicated Intra-Abdominal Infections     12/18/2014
Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial Of Plecanatide In Patients With Irritable Bowel Syndrome With Constipation     12/18/2014
LFB S.A. Announces Achievement Of Patient Enrollment Target For Persept 1 Program For The Evaluation Of Recombinant Factor Seven Efficacy By Prospective Clinical Trials     12/18/2014
Extab Corporation Announces Positive Data From Phase 3 Clinical Study Of Cytisine As A Smoking Cessation Aid Published In The New England Journal Of Medicine     12/18/2014
Hutchison Medipharma Starts Phase III Trial Of Cancer Drug     12/18/2014
TetraLogic Pharmaceuticals (TLOG) Announces Initiation Of A Randomized Phase 2 Clinical Trial Of SHAPE In Subjects With Cutaneous T-Cell Lymphoma     12/18/2014
Fate Therapeutics (FATE) Announces Interim Data From Ongoing Phase 2 PUMA Study     12/18/2014
Biocryst Pharmaceuticals (BCRX) Initiates Opus-2: A Clinical Trial Of BCX4161 In Patients With Hereditary Angioedema     12/18/2014
StemCells Inc. (STEM) Transplants First Participant In Phase 2 Clinical Trial In Cervical Spinal Cord Injury     12/18/2014
Nuvo Research Inc. (NRI.TO) Reports That All Patients Have Completed Phase 2 Study Of WF10 For The Treatment Of Allergic Rhinitis     12/18/2014
D-Pharm Ltd. Achieves Primary End-Point In Phase 2 Clinical Study Of THR-18 In Acute Stroke Patients Treated With tPA     12/18/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Release: Study Further Validates Cell Therapy Approach To Reverse Type 1 Diabetes     12/18/2014
Curis, Inc. (CRIS) Announces Dosing Of First Patient In Phase 1 Trial Of CUDC-907 In Patients With Advanced/ Relapsed Solid Tumors     12/18/2014
Inovio Pharmaceuticals (INO) Initiates DNA Immunotherapy Trial For Breast, Lung And Pancreatic Cancers     12/18/2014
Seattle Genetics, Inc. (SGEN) Initiates Phase 1b Trial Of SGN-CD33A In Combination With Frontline Standard Of Care And As Consolidation Therapy For Acute Myeloid Leukemia     12/18/2014
Dyax Corp. (DYAX)'s First-In-Human Trial For DX-2930 Conducted By Vince And Associates Clinical Research Featured In The Annals Of Allergy, Asthma & Immunology     12/18/2014
e-Therapeutics plc Reports Progress In ETS2101 Phase 1a And Oral Dosing Studies     12/18/2014
Aldeyra Therapeutics (ALDX) Submits FDA IND Filing for Noninfectious Anterior Uveitis     12/18/2014
PHARNEXT Announces Pleotherapy Proof Of Concept In Charcot-Marie-Tooth Disease Type 1A Through Two Peer-Reviewed Publications     12/18/2014
CVS Health Research Institute Data Provides First Look At Rapid Uptake Of New Hepatitis C Treatments And An Expanding Population Of Treated Patients     12/18/2014
Pharmaceutical Research and Manufacturers of America (PhRMA) Release: New Report: Decades Of Drug Research Failures And Successes Transform Hepatitis C From Incurable To Curable Disease     12/18/2014
Natera Release: Published Study Shows Panorama NIPT Is Validated To Screen For Microdeletion Syndromes At 9 Weeks Of Pregnancy     12/18/2014
European Bioinformatics Institute Release: "Hairclip: Protein Mechanism Explained     12/18/2014
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program     12/18/2014
KCR Acquires Project Portfolio From Ukrainian CRO AXIS     12/18/2014
FUJIFILM Completes Acquisition Of Kalon Biotherapeutics     12/18/2014
Prima Biomed (PRR.AX) Completes Immutep S.A. Acquisition     12/18/2014
Chimerix, Inc. (CMRX) And ContraVir Pharmaceuticals Establish Strategic Collaboration For Antiviral Drug Candidate CMX157     12/18/2014
HUYA Bioscience International Establishes Alliance Wth China Wuqing Development Area     12/18/2014
The Medicines Company (MDCO) Reaches $55 Million Licensing Partnership With SciClone Pharmaceuticals, Inc. (SCLN)     12/18/2014
Enamine Ltd. Announces Extension Of Collaboration With Sanofi (SAN.PA) In Early Drug Discovery     12/18/2014
Compugen Ltd. (CGEN) Enters Immuno-Oncology Research Collaboration With Johns Hopkins University     12/18/2014
AHF: Florida Reaches Agreement With Humana, Inc. (HUM) On HIV/AIDS Drug Pricing     12/18/2014
Cellectis Plant Sciences And Two Blades Foundation Announce The Execution Of A Cross-License Agreement On TAL Effector Nuclease Technologies     12/18/2014
Biothera Participates In Cancer Research UK Combinations Alliance     12/18/2014
Strategic Science & Technologies Signs Partnership Agreement With A Leading Global Pharmaceutical Company For U.S. Commercial Rights To Topical Ibuprofen     12/18/2014
Indi Molecular® And Sigma-Aldrich Corporation (SIAL) Establish Collaboration To Explore Use Of PCC Technology In Biological Tools     12/18/2014
Enumeral Biomedical (ENUM) And Merck & Co. (MRK) Form Collaboration For Predicting Clinical Drug Response With Human-Driven Immune Profiling Platform     12/18/2014
Marina Biotech, Inc. (MRNA), MiNA Therapeutics Ink $50 Million R&D Pact     12/18/2014
Axxess Pharma, Inc. Forms Partnership With Roc Nation Sports And Throne Boxing In Promotion Of Tapout Product Line     12/18/2014
WIL Research Partners With Instem For Global Harmonization Project     12/18/2014
Amunix, Inc. Announces Option Exercise By Eli Lilly (LLY) For XTEN™ Product For People With Diabetes     12/18/2014
Somanetics (SMTS) Receives $2,275,000 In NIH Funding To Develop Its RNAi Therapeutics And microRNA Technologies     12/18/2014
NVN Therapeutics Launches Estracool™ Dietary Supplement For Reduction Of Menopausal Symptoms     12/18/2014
Putney, Inc. Launches Carprofen Chewable Tablets     12/18/2014
Celator Pharmaceuticals, Inc. Receives European Patent Allowance On Nanoparticle Delivery Technology     12/18/2014
Pronutria Biosciences Announces Issuance Of Key Patents From USPTO On Compositions And Methods Relating To Oral Biologics     12/18/2014
SPR Advanced Technologies Receives Funding From USAID To Deploy Innovative Solution To Combat Ebola Epidemic     12/18/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Completes Public Offering of Common Stock     12/18/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)     12/18/2014
CytoSorbents, Inc. Receives NASDAQ Listing Approval     12/18/2014
CB Pharma Acquisition Corp. Announces Closing Of Initial Public Offering     12/18/2014
Trillium Therapeutics Inc. To List Common Shares On The NASDAQ Capital Market Under The Symbol TRIL     12/18/2014
Oasis Health Products, Inc. Announces Completion Of Stability Testing On Itonis, Inc.'s EMESYL Nausea Relief     12/18/2014
Cara Therapeutics, Inc. (CARA) Announces Addition To The NASDAQ Biotechnology Index     12/18/2014
Nuvilex (NVLX)'s Partner Austrianova Successfully Completes First Live Cell Encapsulation In New Facility     12/18/2014
Cipher Pharmaceuticals (DND.TO) Announces Adoption Of Advance Notice By-Law     12/18/2014
American Diabetes Association Announces 2015 Legislative And Regulatory Priorities     12/18/2014
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders     12/18/2014
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders     12/18/2014
Cell MedX Corp. (CMXC) Announces The First Order Received By Its Newly Formed Wholly Owned Subsidiary     12/18/2014
Amneal Pharmaceuticals Selects Revitas Revenue Management Suite     12/18/2014
Reflect Scientific, Inc. Sees Strong Year End Shipments     12/18/2014
Bellicum Pharmaceuticals, Inc. Prices Initial Public Offering Of 7,350,000 Shares Of Common Stock     12/18/2014
Successful FDA Inspection At Hovione     12/18/2014
Lifeline Pharmaceuticals Announces New Mississippi Distribution Center     12/18/2014
Amgen (AMGN) Announces 30 Percent Increase In 2015 First Quarter Dividend     12/18/2014
BioReference Laboratories, Inc. (BRLI) Announces Quarterly And Yearly Record Revenues, Net Income And Patient Volumes     12/18/2014
Baxter International, Inc. (BAX) Fourth Quarter 2014 Financial Results Conference Call     12/18/2014
NeuroDerm Ltd. (NDRM) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update     12/18/2014
Neogen Corporation (NEOG) Reports 26% Increase In Net Income     12/18/2014
Verastem, Inc. (VSTM) Appoints Daniel Paterson As Chief Operating Officer     12/18/2014
Dr. Michael A Ross, MD, Appointed As CEO Of Euclid Systems Corporation     12/18/2014
Claritas Genomics Appoints Patrick F. Terry As Chief Commercial Officer     12/18/2014
MonoSolRx LLC Names A. Mark Schobel Chief Innovation & Technology Officer; Keith Kendall Assumes Role Of CEO     12/18/2014
Protagonist Therapeutics Names William A. Hodder As Senior Vice President, Corporate Development     12/18/2014
Dicerna Pharmaceuticals (DRNA) Announces The Appointment Of Theodore T. Ashburn, M.D., Ph.D. To Senior Vice President, Product Strategy And Operations, And Inducement Grant Of Stock Options Under NASDAQ Listing Rule 5635 (C)(4)     12/18/2014
Daxor Corporation (DXR) Appoints Michael Feldschuh As Executive Vice President     12/18/2014
Alnylam Pharmaceuticals (ALNY) Elects Michael W. Bonney To Its Board Of Directors     12/18/2014
Celldex Therapeutics, Inc. (CLDX) Announces Appointment To Board Of Directors     12/18/2014
Chimerix, Inc. (CMRX) Appoints Ronald C. Renaud, Jr. To Board Of Directors     12/18/2014
Pacific Biosciences (PACB) Appoints Kathy Ordonez To Board Of Directors     12/18/2014
PDS Biotechnology Corporation Announces Appointment Of Biotech Industry Leader Sir Richard Sykes To Its Board Of Directors As Executive Chairman     12/18/2014
Raptor Pharmaceutical Inc. (RPTP) Appoints Gregg Lapointe And Georges Gemayel To Board Of Directors     12/18/2014
ABIVAX, A Privileged Partner Of The Cuban Life Science Industry, Welcomes Initiative To Renew Relations Between The U.S.A. And Cuba     12/18/2014
Nutra Pharma Corp. (NPHC) Announces Manufacturing Release Of Pet Pain-Away And Delivery Of Initial Orders     12/18/2014
PHT Corporation Achieves Certification To Use The Clinician Version Of The Columbia Suicide Severity Rating Scale (C-SSRS) On Sitepad® Tablets In Clinical Trials     12/18/2014
Celgene (CELG) Earns CEO Cancer Gold Standard Accreditation     12/18/2014
eClinical Solutions Achieves Accreditation On Medidata Rave® Safety Gateway     12/18/2014
Oxford Gene Technology Ltd.’s Christmas Challenge—Help Santa And Win An Amazon Kindle Fire     12/18/2014
Appistry, Inc. Announces New Fellowship In Life Science Informatics And Entrepreneurship     12/18/2014
France Biotech Presents The Results Of Its Twelfth Annual Survey, « Panorama Of The Life Sciences® »     12/18/2014
NMS Labs And StopDUID.Org Sponsor Update Of 50 States DUI Law Compilation     12/18/2014
BrainLAB AG: Radiating Hope Charity Connects Clinical Experts To Radiation Clinics In Developing Countries Using Quentry® Image Sharing And Collaboration     12/18/2014
Arch Therapeutics To Present At The Biotech Showcase(TM) 2015 Conference On January 14th 2015     12/18/2014
Medivation, Inc. (MDVN) Announces Participation At Upcoming Investor Conference     12/18/2014
Anavex Life Sciences Corp. (AVXL.OB) To Present At Biotech Showcase 2015 In San Francisco     12/18/2014
Cytori Therapeutics, Inc. (CYTX) To Provide Corporate Update At 2015 Biotech Showcase In San Francisco     12/18/2014
Biothera Participates In Cancer Research UK Combinations Alliance     12/18/2014
Abbott Laboratories (ABT) To Present At J.P. Morgan Healthcare Conference     12/18/2014
Astellas To Present At J.P. Morgan Healthcare Conference     12/18/2014

Career Tips
How To Get Noticed By Employers: Advice From Cliniqa And DexCom (DXCM)     12/18/2014
Best Cover Letter Tips For 2015     12/18/2014
Top 10 Resume Tips For 2015     12/18/2014
5 Crucial Cover Letter Mistakes     12/18/2014
What AstraZeneca PLC (AZN) Is Looking For In Hiring Scientists And Execs     12/5/2014
3 Cover Letter Mistakes You May Not Realize You've Made     12/4/2014
5 Myths About HR During The Job Inteview Debunked     12/4/2014
Avoid These 4 Common Resume Flaws     12/4/2014
Top 10 Biotech Careers Ranked     12/3/2014
Ardea Biosciences, Inc. HR VP Shares A Fool-Proof Guide To Joining A Startup     11/20/2014
3 Signs Your Resume Isn't Working     11/20/2014
3 Deadly Mistakes Made In Job Interviews     11/20/2014
4 Essentials Of A Good Cover Letter     11/20/2014
Sanofi (SAN.PA) And Incyte Corporation (INCY) Execs Exclusive: Future Hiring Trends And What They're Looking For In New Hires     11/7/2014
4 Common Mistakes That Sabotage Your Resume     11/6/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->